Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
ILIVER|July 10, 2025
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosisHuiying Rao, Jia Shang, Qing Xie, et al.
The Lancet Regional Health. Western Pacific|July 10, 2023
Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluationSihui Zhang, Chao Wang, Bei Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2025
External Validation of the GOLDEN Model for Predicting HBsAg Loss in Noncirrhotic Chronic Hepatitis B Patients With Interferon-Alpha-Based TherapyXingmei Liao, Qing Xie, Xiaoguang Dou, et al.
Gut|June 20, 2024
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapyRong Fan, Siru Zhao, Junqi Niu, et al.
Nature Communications|June 4, 2024
Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2αJialin Xia, Hong Chen, Xiaoxiao Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2013
Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese womenChangsheng Qiu, Hongjie Chen, Junping Wen, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2021
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapyRong Fan, Junqi Niu, Hong Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis BShi Liu, Grace Lai-Hung Wong, Rong Fan, et al.
JAMA Ophthalmology|June 4, 2026
Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical TrialRuixin Wang, Shaowei Bi, Duoru Lin, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Cuisong Wu, Guijie Xin, et al.
Pageof 11